The Truth About Dr. Simon Ourian’s Non-Invasive Facelift
Nov 09, 2022 (The Kerplunk) — BEVERLY HILLS, California-Dr. Simon Ourian, a leading authority in the field of cosmetic dermatology and the founder of Epione Salon, has begun offering patients his signature One-Hour Facelift. The incisionless procedure, whose endorsers include Kris Jenner, uses state-of-the-art lasers and stem cell/exosome technology to stimulate the body to repair and refresh itself naturally and without pain.
“I am very excited to offer patients the latest in regenerative medicine for skincare, which may soon replace the traditional facelift altogether,” says Dr. Simon. “The approach that I have invented and refined improves upon old-school lasers that were either too weak to provide noticeable effects or were so strong that they necessitated an extended recovery. I collaborated with the world’s leading laser manufacturer to design a happy medium, one that results in rejuvenated skin and only a week’s downtime.”
He explains that the One-Hour Facelift combines his patented Coolaser(R) technology with an innovative stem cell-injection procedure. Most people think of lasers as generating heat, but Dr. Simon’s dual-mode, high-definition, fractionated CO2 laser actually cools the skin.
“That’s one of the first differences patients immediately notice,” says Dr. Simon. “One of the Coolaser(R)’s many benefits include protection for dark skin, as it does not pigment it. The Coolaser(R) can be used on many skin types and tones to erase discoloration, including dark circles and acne, and to tighten and improve the feel of your skin. It is also excellent for preventing wrinkles.”
A crucial component of his One-Hour Facelift are stem cell injections. The use of stem cells in medicine began in orthopedics and in the healing of wounds. Dr. Simon, however, has brought them into his regenerative treatments for the skin.
“The stem cells are taken from the patient’s body, medically processed, and then applied to the face via a syringe,” says Dr. Simon. “Stem cells ultimately stimulate the regeneration of skin tissue, secrete anti-inflammatory agents and antioxidants, and neutralize free radicals. What that means for the patient is improved skin density, hydration, and appearance, with healing that goes right down to the dermis layer of the skin. Even better, it’s all without pain medications, scarring, or long recovery periods.”
The One-Hour Facelift created by Dr. Simon is finding many supporters, including Kim Kardashian, who has described him as a “necessity.” He frequently posts before-and-after photos on Instagram, where the results of his approach to rejuvenating the skin can be seen.
“I am happy to provide my patients with a 21st-century facelift that is performed in under sixty minutes and without a scalpel,” says Dr. Simon. “It is the culmination of my life’s work: to take the pain out of beauty, finetune the features of patients, and let them heal naturally.”
Dr. Simon Ourian is the founder of Epione Beverly Hills, the world’s most advanced laser and aesthetic treatment center. With more than 3.5M Instagram fans, Dr. Simon is also the creator of the One-Hour Facelift, the non-invasive aesthetic procedure that refreshes skin through the use of Coolaser technology and stem cell injections. For more information on the advanced treatments that Dr. Simon uses to help patients reach their beauty goals, please check out the before-and-after photos, see his website, or contact:
Dr. Simon Ourian
Always consult your healthcare professional for specific advice related to your medical conditions and treatment, including all risks and potential benefits of undergoing this treatment. Only your healthcare professional can assess whether you are an appropriate candidate for this procedure.
The post The Truth About Dr. Simon Ourian’s Non-Invasive Facelift appeared first on The Kerplunk.
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.